I2I
ZBH icon

Insight 2811 Inc’s Zimmer Biomet ZBH Stock Holding History

Insight 2811 Inc’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,421
Closed -$207K – 100
2023
Q2 		$207K Buy
+1,421
New +$193K 0.11% 87
2022
Q4 		– Sell
-3,400
Closed -$355K – 102
2022
Q3 		$355K Buy
3,400
+100
+3% +$11K 0.24% 53
2022
Q2 		$347K Sell
3,300
-100
-3% -$11.9K 0.23% 51
2022
Q1 		$435K Buy
+3,400
New +$410K 0.26% 50

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Insight 2811 Inc's ZBH Position: Q3 2023 in Review

Insight 2811 Inc sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,421 shares — an estimated $207K sold.

Insight 2811 Inc first reported a position in ZBH in Q1 2022 and held it in 4 quarters. The position peaked at $435K in Q1 2022. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Insight 2811 Inc reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • Insight 2811 Inc sold 1,421 Zimmer Biomet shares in Q3 2023, an estimated $207K.
  • Insight 2811 Inc first reported a position in Zimmer Biomet in Q1 2022 and held it in 4 quarters.
  • Insight 2811 Inc's Zimmer Biomet position peaked at $435K in Q1 2022.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Insight 2811 Inc's 13F filing for Q3 2023, filed 14 Nov 2023.